B-Luc-EGFP SU-DHL-1

• 322063

B-Luc-EGFP SU-DHL-1

Product nameB-Luc-EGFP SU-DHL-1
Catalog number322063
TissueLymphoma
DiseaseLarge cell lymphoma; ddiffusehistiocytic lymphoma
SpeciesHuman
ApplicationB-Luc-EGFP SU-DHL-1 cell line can be used to evaluate anti-cancer drugs in large cell lymphoma or ddiffuse histiocytic lymphoma in vivo

on this page

  • Description
  • Targeting strategy
  • Phenotypic analysis
  • Tumorigenicity

Posters

View All

    Publication

      Description

      This B-Luc-EGFP SU-DHL-1 cell line expresses firefly luciferase as a marker of SU-DHL-1 cells. Fluorescence and EGFP could be detected in B-Luc-EGFP SU-DHL-1 cells.

      Targeting strategy

      Gene targeting strategy for B-Luc-EGFP SU-DHL-1 cells. The CMV promoter and luciferase-EGFP were inserted into the targeting vector used in the lentivirus system.

      In vitro luciferase activity of B-Luc-EGFP SU-DHL-1 cells

      Luminescence signal intensity of B-Luc-EGFP SU-DHL-1 cells. Luminescence intensity was measured using the Bright-GloTM luciferase Assay. B-Luc-EGFP SU-DHL-1 cells have a strong luminescence signal. EGFP was detected in B-Luc-EGFP SU-DHL-1 cells. The 1-D10 clone of B-Luc-EGFP SU-DHL-1 cells can be used in vivo experiments.

      Quantitative imaging data & body weight changes

      B-Luc-EGFP SU-DHL-1 cells (5x106) were injected into the tail vein of wild-type B-NDG mice. Signal intensity and body weight were measured twice a week. (A) Imaging was performed twice a week. (B) Body weight (Mean ± SEM). B-Luc-EGFP SU-DHL-1 cells can be used for in vivo efficacy evaluation.